STAT3 and gastric cancer: Mechanism researches suggested that SIRT1 can counteract the activation of STAT3 and NF-κB to repress cell growth [33] and lead to G1-phase arrest via NF-κB/Cyclin D1 signaling in gastric cancer[34].